CXCL12 and lip and oral cavity carcinoma: We investigated novel therapeutic downstream target(s) of the SDF-1/CXCR4 system using the oral cancer cells, B88-SDF-1, which have an autocrine SDF-1/CXCR4 system and exhibit distant metastatic potentials in vivo.